Advance Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Advance Capital Management's PFE Position: Q3 2026 in Review
Advance Capital Management increased its Pfizer (PFE) stake by 12% in Q3 2026, buying an estimated $70.6K and bringing the position to 25,696 shares worth $733K. The position accounts for 0.02% of the portfolio, ranked #97.
Advance Capital Management first reported a position in PFE in Q4 2021 and has held it in 20 quarters since. 2,915 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Advance Capital Management held 25,696 shares of Pfizer worth $733K as of Q3 2026.
- Advance Capital Management bought 2,654 Pfizer shares in Q3 2026, an estimated $70.6K.
- Pfizer made up 0.02% of Advance Capital Management's portfolio in Q3 2026, its #97 holding.
- Advance Capital Management first reported a position in Pfizer in Q4 2021 and has held it in 20 quarters since.
- 2,915 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Advance Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.